Howard I. Hurtig

23.2k citations

140 papers · 13.9k indexed · 2 hit papers · h-index 63

Neurology top 0.02%
- Parkinson's Disease Mechanisms and Treatments 84
- Neurological disorders and treatments 44
- Neurological diseases and metabolism 11
Neurology top 0.2%
- Parkinson's Disease Mechanisms and Treatments 84
- Neurological disorders and treatments 44
- Neurological diseases and metabolism 11
Cellular and Molecular Neuroscience top 0.5%
- Genetic Neurodegenerative Diseases 18
Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research 25
Physiology top 0.5%
- Alzheimer's disease research and treatments 39
Cognitive Neuroscience
- Neurobiology of Language and Bilingualism 20
Developmental and Educational Psychology
- Language Development and Disorders 8

Co-authors: John Q. Trojanowski Virginia M.‐Y. Lee John E. Duda Matthew B. Stern Andrew Siderowf Benoit I. Giasson Daniel Weintraub Murray Grossman
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Science (1 paper)PLoS ONE (2 papers)American Journal of Psychiatry (1 paper)
Partner nations: United States Canada Germany

In The Last Decade

Howard I. Hurtig

140 papers receiving 13.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Howard I. Hurtig

Since Specialization

Citations

This map shows the geographic impact of Howard I. Hurtig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard I. Hurtig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard I. Hurtig more than expected).

Fields of papers citing papers by Howard I. Hurtig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard I. Hurtig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard I. Hurtig. The network helps show where Howard I. Hurtig may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Howard I. Hurtig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Howard I. Hurtig Line = papers co-authored together Howard I. Hurtig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia PLoS ONE ·Rizwan Akhtar,Sharon X. Xie,Yin J. Chen,Jacqueline Rick,Owen A. Ross,Ilya M. Nasrallah,Vivianna M. Van Deerlin,John Q. Trojanowski,Alice Chen‐Plotkin,Howard I. Hurtig,Andrew Siderowf,Jacob G. Dubroff,Daniel Weintraub	2017	31
2	Point pressure sensitivity in early stage Parkinson's disease Physiology & Behavior ·Richard L. Doty,Shifa S. Gandhi,Allen Osman,Howard I. Hurtig,Ian Pawasarat,Evan Beals,Inna Chung,Jacob G. Dubroff,Andrew B. Newberg,Gui-Shang Ying,Fidias E. Leon‐Sarmiento	2014	5
3	Taste function in early stage treated and untreated Parkinson’s disease Journal of Neurology ·Richard L. Doty,Michael T. Nsoesie,Inna Chung,Allen Osman,Ian Pawasarat,Julie Caulfield,Howard I. Hurtig,Jonathan Silas,Jacob G. Dubroff,John E. Duda,Gui‐Shuang Ying,Hakan Tekelı,Fidias E. Leon‐Sarmiento	2014	35
4	CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease Neurology ·Andrew Siderowf,Sharon X. Xie,Howard I. Hurtig,Daniel Weintraub,John E. Duda,Alice Chen‐Plotkin,Leslie M. Shaw,Vivianna M. Van Deerlin,John Q. Trojanowski,C. Clark	2010	281
5	Novel CSF biomarkers for frontotemporal lobar degenerations Neurology ·William T. Hu,Alice Chen‐Plotkin,Owen A. Ross,Steven E. Arnold,Christopher M. Clark,Les Shaw,Leo McCluskey,Igor Elman,Howard I. Hurtig,Andrew Siderowf,V.M.-Y. Lee,Holly Soares,John Q. Trojanowski	2010	74
6	TDP-43 pathology occurs infrequently in multiple system atrophy Neuropathology and Applied Neurobiology ·Felix Geser,Joseph A. Malunda,Howard I. Hurtig,John E. Duda,Gregor K. Wenning,S. Gilman,Phillip A. Low,V. M.‐Y. Lee,John Q. Trojanowski	2010	25
7	Long‐term outcome of early versus delayed rasagiline treatment in early Parkinson's disease Movement Disorders ·Robert A. Hauser,Mark Lew,Howard I. Hurtig,William G. Ondo,Joanne Wojcieszek,Cheryl Fitzer‐Attas,(unknown)	2008	94
8	Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores Parkinsonism & Related Disorders ·Eugenia Mamikonyan,Paul J. Moberg,Andrew Siderowf,John E. Duda,Tom Ten Have,Howard I. Hurtig,Matthew B. Stern,Daniel Weintraub	2008	146
9	Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations Neurology ·A. S. Chen-Plotkin,Wuxing Yuan,C. Anderson,Elisabeth McCarty Wood,Howard I. Hurtig,C. M. Clark,B. L. Miller,V. M.-Y. Lee,J. Q. Trojanowski,M. Grossman,Vivianna M. Van Deerlin	2007	42
10	Glucocerebrosidase mutations are an important risk factor for Lewy body disorders Neurology ·Özlem Göker-Alpan,Benoit I. Giasson,Michael J. Eblan,Joann Nguyen,Howard I. Hurtig,V. M.-Y. Lee,John Q. Trojanowski,Ellen Sidransky	2006	168
11	Long-Term Outcomes of Bilateral Subthalamic Nucleus Stimulation in Patients with Advanced Parkinson’s Disease Stereotactic and Functional Neurosurgery ·Grace Liang,Kelvin L. Chou,Gordon H. Baltuch,Jurg L. Jaggi,Catherine Loveland‐Jones,Lewis Z. Leng,Heather Maccarone,Howard I. Hurtig,Amy Colcher,Matthew B. Stern,Galit Kleiner‐Fisman,Tanya Simuni,Andrew Siderowf	2006	69
12	Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy Acta Neuropathologica ·Benoit I. Giasson,Meghann E. Mabon,John E. Duda,Thomas J. Montine,David Robertson,Howard I. Hurtig,Virginia M.‐Y. Lee,John Q. Trojanowski	2003	32
13	Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety Journal of neurosurgery ·Tanya Simuni,Jurg L. Jaggi,Heather Mulholland,Howard I. Hurtig,Amy Colcher,Andrew Siderowf,Bernard Ravina,Brett E. Skolnick,Reid Goldstein,Matthew B. Stern,Gordon H. Baltuch	2002	121
14	Dopamine supports sentence comprehension in Parkinson’s Disease Journal of the Neurological Sciences ·Murray Grossman,Guila Glosser,Julia Kalmanson,Jennifer Morris,Matthew B. Stern,Howard I. Hurtig	2001	52
15	Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies American Journal Of Pathology ·John E. Duda,Benoit I. Giasson,Qiping Chen,Tamar Gur,Howard I. Hurtig,Matthew B. Stern,Steven M. Gollomp,Harry Ischiropoulos,Virginia M.‐Y. Lee,John Q. Trojanowski	2000	226
16	Attention and Sentence Processing Deficits in Parkinson's Disease: The Role of Anterior Cingulate Cortex Cerebral Cortex ·Murray Grossman,Peter B. Crino,Martin Reivich,Matthew B. Stem,Howard I. Hurtig	1992	63
17	Epitopes located in spatially separate domains of each neurofilament subunit are present in parkinson's disease lewy bodies The Journal of Comparative Neurology ·William Hill,Virginia M.‐Y. Lee,Howard I. Hurtig,John M. Murray,John Q. Trojanowski	1991	92
18	Neuropsychological functioning in hemiparkinsonism Brain and Cognition ·Lee X. Blonder,Raquel E. Gur,Ruben C. Gur,Andrew J. Saykin,Howard I. Hurtig	1989	60
19	Symptomatic hydrocephalus and reversible spinal cord compression in Listeria monocytogenes meningitis Journal of neurosurgery ·Eric C. Raps,David H. Gutmann,James R. Brorson,Michael K. O’Connor,Howard I. Hurtig	1989	10
20	Selective Expression of Epitopes in Multiphosphorylation Repeats of the High and Middle Molecular Weight Neurofilament Proteins in Alzheimer Neurofibrillary Tangles Annals of Medicine ·John Q. Trojanowski,Maria Luiza Gava Schmidt,László Ötvös,Ruben C. Gur,Raquel E. Gur,Howard I. Hurtig,Virginia M.‐Y. Lee	1989	11

About Howard I. Hurtig

Howard I. Hurtig is a scholar working on Neurology, Neurology and Psychiatry and Mental health, having authored 140 papers that have together received 13.9k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (84 papers), Neurological disorders and treatments (44 papers), Alzheimer's disease research and treatments (39 papers), Dementia and Cognitive Impairment Research (25 papers), Neurobiology of Language and Bilingualism (20 papers), Genetic Neurodegenerative Diseases (18 papers), Neurological diseases and metabolism (11 papers) and Language Development and Disorders (8 papers). The work is most often cited by research in Neurology (9.5k citations), Neurology (2.1k citations) and Cellular and Molecular Neuroscience (3.0k citations). Howard I. Hurtig has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include John Q. Trojanowski, Virginia M.‐Y. Lee, John E. Duda, Matthew B. Stern, Andrew Siderowf, Benoit I. Giasson, Daniel Weintraub, Murray Grossman, M. B. Stern and Vivianna M. Van Deerlin. Their work appears in journals such as Science, PLoS ONE and American Journal of Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact